Literature DB >> 30246693

T Helper Cells Profile and CD4+CD25+Foxp3+Regulatory T Cells in Polycystic Ovary Syndrome.

Fatemeh Nasri1, Mehrnoosh Doroudchi, Bahia Namavar Jahromi, Behrouz Gharesi-Fard.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is considered as the most common cause of female infertility that affects 4-10% of women in the reproductive age. Previous studies have shown the role of a balanced immune response in a successful pregnancy and fertility.
OBJECTIVE: To investigate the T helper cells type 1 (Th1) /Th2/Th17/Treg paradigms in peripheral blood of infertile PCOS compared with normal fertile women.
METHODS: Peripheral blood mononuclear cells (PBMCs) were isolated at the late follicular phase from 10 PCOS and 10 fertile women. PBMCs were stimulated with PMA and ionomycin in the presence of Berefeldin A as Golgi stop agent to detect intracellular cytokine production (IFN-γ, IL-17, and IL-4) from CD3+CD4+T cells population indicating T helper (Th) cells subsets by flowcytometry. Moreover, regulatory T cells were enumerated using CD25 and Foxp3 markers.
RESULTS: In this study, we report that the frequency of Th1 cells was increased compared to Th2 cells in infertile PCOS when considering Th1/Th2 ratio (P=0.05). Analysis of Th17/Th2 ratio showed a significant difference with a bias toward Th17 dominancy in PCOS (P=0.02). The proportion of CD4+CD25+Foxp3+ regulatory T cells was significantly lower in PCOS patients than that of healthy fertile women (P=0.02).
CONCLUSION: In summary, Th1 and Th17 bias and reduction of Treg and Th2 cells as regulators of immune responses might be involved in the pathogenesis of PCOS. These results are suggestive of an altered immune response to inflammatory status in PCOS patients, likely causing some complications such as infertility in these patients.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30246693     DOI: 10.22034/IJI.2018.39387

Source DB:  PubMed          Journal:  Iran J Immunol        ISSN: 1735-1383            Impact factor:   1.603


  9 in total

1.  Peripheral Blood Inflammatory-Immune Cells as a Predictor of Infertility in Women with Polycystic Ovary Syndrome.

Authors:  ShuQiong He; XiaoDan Mao; HuiFang Lei; BinHua Dong; DanHua Guo; BeiHong Zheng; PengMing Sun
Journal:  J Inflamm Res       Date:  2020-08-18

Review 2.  The immune system's role in PCOS.

Authors:  Maryam Shamsi; Ali Ghazavi; Amir Mohammad Saeedifar; Ghasem Mosayebi; Sana Khajeh Pour; Ali Ganji
Journal:  Mol Biol Rep       Date:  2022-06-25       Impact factor: 2.316

Review 3.  Immunophenotypic Profiles in Polycystic Ovary Syndrome.

Authors:  Cong Hu; Bo Pang; Zhanchuan Ma; Huanfa Yi
Journal:  Mediators Inflamm       Date:  2020-03-19       Impact factor: 4.711

Review 4.  Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights.

Authors:  Antonio Mancini; Carmine Bruno; Edoardo Vergani; Claudia d'Abate; Elena Giacchi; Andrea Silvestrini
Journal:  Int J Mol Sci       Date:  2021-02-07       Impact factor: 5.923

5.  Modulatory effects of R10 fraction of garlic (Allium sativum L.) on hormonal levels, T cell polarization, and fertility-related genes in mice model of polycystic ovarian syndrome.

Authors:  Somaye Falahatian; Raheem Haddad; Nafiseh Pakravan
Journal:  J Ovarian Res       Date:  2022-01-06       Impact factor: 4.234

6.  Involvement of impaired CD8+ mucosal-associated invariant T cells and myeloid-derived suppressor cells in polycystic ovary syndrome.

Authors:  Mengting Zhu; Yuping Xu; Caihua Li; Zhimin Lu; Kaihuan Bi; Kangxia Wang; Peipei Guo; Huanhuan Jiang; Yunxia Cao
Journal:  Reprod Biol Endocrinol       Date:  2021-11-30       Impact factor: 5.211

7.  The abnormal level of HSP70 is related to Treg/Th17 imbalance in PCOS patients.

Authors:  Yiqing Yang; Jing Xia; Zhe Yang; Gengxiang Wu; Jing Yang
Journal:  J Ovarian Res       Date:  2021-11-15       Impact factor: 4.234

Review 8.  Implications of regulatory T cells in non-lymphoid tissue physiology and pathophysiology.

Authors:  Darya Malko; Tarek Elmzzahi; Marc Beyer
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

Review 9.  Therapeutic Potentials of Low-Dose Tacrolimus for Aberrant Endometrial Features in Polycystic Ovary Syndrome.

Authors:  Ahmad J H Albaghdadi; Frederick W K Kan
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.